Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 2
1988 3
1989 4
1990 2
1991 4
1993 2
1994 2
1996 4
1998 2
1999 2
2000 1
2001 1
2002 1
2003 2
2004 2
2005 8
2006 4
2007 4
2008 7
2009 6
2010 7
2011 12
2012 9
2013 5
2014 10
2015 10
2016 5
2017 12
2018 11
2019 10
2020 8
2021 10
2022 14
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Results by year

Filters applied: . Clear all
Page 1
Arrhythmogenic Right Ventricular Cardiomyopathy.
Krahn AD, Wilde AAM, Calkins H, La Gerche A, Cadrin-Tourigny J, Roberts JD, Han HC. Krahn AD, et al. JACC Clin Electrophysiol. 2022 Apr;8(4):533-553. doi: 10.1016/j.jacep.2021.12.002. JACC Clin Electrophysiol. 2022. PMID: 35450611 Free article. Review.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) encompasses a group of conditions characterized by right ventricular fibrofatty infiltration, with a predominant arrhythmic presentation. First described in the late 1970s and early 1980s, i …
Arrhythmogenic right ventricular cardiomyopathy (ARVC) encompasses a group of conditions characterized by right …
Arrhythmogenic right ventricular dysplasia/cardiomyopathy.
El Masry HZ, Yadav AV. El Masry HZ, et al. Expert Rev Cardiovasc Ther. 2008 Feb;6(2):249-60. doi: 10.1586/14779072.6.2.249. Expert Rev Cardiovasc Ther. 2008. PMID: 18248278 Review.
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a cardiac disease characterized by fibrofatty replacement of the cardiac myocytes. Patients with ARVD/C frequently present with ventricular tachycardia and many are thought to …
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a cardiac disease characterized by fibrofa …
Arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Prakasa KR, Calkins H. Prakasa KR, et al. Curr Treat Options Cardiovasc Med. 2005 Dec;7(6):467-75. doi: 10.1007/s11936-005-0032-0. Curr Treat Options Cardiovasc Med. 2005. PMID: 16283974
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a genetic cardiomyopathy characterized by ventricular arrhythmias and structural abnormalities of the right ventricle (RV). ...We encourage patients to participate in t …
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a genetic cardiomyopathy characterized by …
Pharmacotherapy and other therapeutic modalities for managing Arrhythmogenic Right Ventricular Cardiomyopathy.
Rigato I, Corrado D, Basso C, Zorzi A, Pilichou K, Bauce B, Thiene G. Rigato I, et al. Cardiovasc Drugs Ther. 2015 Apr;29(2):171-7. doi: 10.1007/s10557-015-6583-8. Cardiovasc Drugs Ther. 2015. PMID: 25894016 Review.
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is a genetically determined rare cardiomyopathy (1 in 5000 to 1 in 2000 in the general population), which can lead to ventricular arrhythmias and sudden death (SD). The classic form of the disease …
Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is a genetically determined rare cardiomyopathy (1 in 5000 to 1 …
Arrhythmogenic right ventricular cardiomyopathy/dysplasia: risk stratification and therapy.
Buja G, Estes NA 3rd, Wichter T, Corrado D, Marcus F, Thiene G. Buja G, et al. Prog Cardiovasc Dis. 2008 Jan-Feb;50(4):282-93. doi: 10.1016/j.pcad.2007.10.004. Prog Cardiovasc Dis. 2008. PMID: 18156007 Free PMC article. Review.
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an inherited heart muscle disease that occurs primarily in young and middle-age individuals. ...The main questions regarding the risk stratification and the therapeutic strategy in A …
Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is an inherited heart muscle disease that occ …
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe.
Carrick RT, De Marco C, Gasperetti A, Bosman LP, Gourraud JB, Trancuccio A, Mazzanti A, Murray B, Pendleton C, Tichnell C, Tandri H, Zeppenfeld K, Wilde AAM, Davies B, Seifer C, Roberts JD, Healey JS, MacIntyre C, Alqarawi W, Tadros R, Cutler MJ, Targetti M, Calò L, Vitali F, Bertini M, Compagnucci P, Casella M, Dello Russo A, Cappelletto C, De Luca A, Stolfo D, Duru F, Jensen HK, Svensson A, Dahlberg P, Hasselberg NE, Di Marco A, Jordà P, Arbelo E, Moreno Weidmann Z, Borowiec K, Delinière A, Biernacka EK, van Tintelen JP, Platonov PG, Olivotto I, Saguner AM, Haugaa KH, Cox M, Tondo C, Merlo M, Krahn AD, Te Riele ASJM, Wu KC, Calkins H, James CA, Cadrin-Tourigny J. Carrick RT, et al. Eur Heart J. 2024 Feb 16;45(7):538-548. doi: 10.1093/eurheartj/ehad799. Eur Heart J. 2024. PMID: 38195003 Free PMC article.
BACKGROUND AND AIMS: Implantable cardioverter-defibrillators (ICDs) are critical for preventing sudden cardiac death (SCD) in arrhythmogenic right ventricular cardiomyopathy (ARVC). This study aims to identify cross-continental differences in utilization of p …
BACKGROUND AND AIMS: Implantable cardioverter-defibrillators (ICDs) are critical for preventing sudden cardiac death (SCD) in arrhythmoge …
Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy.
Cappelletto C, Gregorio C, Barbati G, Romani S, De Luca A, Merlo M, Mestroni L, Stolfo D, Sinagra G. Cappelletto C, et al. Int J Cardiol. 2021 Jul 1;334:58-64. doi: 10.1016/j.ijcard.2021.04.069. Epub 2021 May 5. Int J Cardiol. 2021. PMID: 33961942
OBJECTIVES: The aim of our study was to investigate the benefit of antiarrhythmic drugs (AAD) - beta-blockers, sotalol or amiodarone - in a cohort of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) patients with long-term longitudinal follow up. ...MET …
OBJECTIVES: The aim of our study was to investigate the benefit of antiarrhythmic drugs (AAD) - beta-blockers, sotalol or amiodarone - in a …
Safety and efficacy of flecainide associated with beta-blockers in arrhythmogenic right ventricular cardiomyopathy.
Rolland T, Badenco N, Maupain C, Duthoit G, Waintraub X, Laredo M, Himbert C, Frank R, Hidden-Lucet F, Gandjbakhch E. Rolland T, et al. Europace. 2022 Feb 2;24(2):278-284. doi: 10.1093/europace/euab182. Europace. 2022. PMID: 34459901
AIMS: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy associated with a high risk of ventricular arrhythmia (VA). ...No Brugada-induced electrocardiography pattern on flecainide or haemodynamic impairment was repor …
AIMS: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy associated with a high risk …
Identification of Cadherin 2 (CDH2) Mutations in Arrhythmogenic Right Ventricular Cardiomyopathy.
Mayosi BM, Fish M, Shaboodien G, Mastantuono E, Kraus S, Wieland T, Kotta MC, Chin A, Laing N, Ntusi NB, Chong M, Horsfall C, Pimstone SN, Gentilini D, Parati G, Strom TM, Meitinger T, Pare G, Schwartz PJ, Crotti L. Mayosi BM, et al. Circ Cardiovasc Genet. 2017 Apr;10(2):e001605. doi: 10.1161/CIRCGENETICS.116.001605. Circ Cardiovasc Genet. 2017. PMID: 28280076 Clinical Trial.
BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetically heterogeneous condition caused by mutations in genes encoding desmosomal proteins in up to 60% of cases. ...High-resolution melting analysis followed by Sanger sequencing was …
BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetically heterogeneous condition caused by m …
Incidence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: a pooled analysis.
Agbaedeng TA, Roberts KA, Colley L, Noubiap JJ, Oxborough D. Agbaedeng TA, et al. Europace. 2022 Oct 13;24(10):1665-1674. doi: 10.1093/europace/euac014. Europace. 2022. PMID: 35298614 Free PMC article.
AIMS: Arrhythmogenic right ventricular cardiomyopathy (ARVC), an inherited heart muscle abnormality, is a major cause of sudden cardiac death (SCD). ...Multivariable predictors of life-threatening arrhythmic events including SCD were: age at presentation [adj …
AIMS: Arrhythmogenic right ventricular cardiomyopathy (ARVC), an inherited heart muscle abnormality, is a major cause o …
175 results